Evidence map›Paper›PMID 25781654›Full record

Trial reportPloS one2015

Effects of acute exposure to increased plasma branched-chain amino acid concentrations on insulin-mediated plasma glucose turnover in healthy young subjects.

Sarah Everman, Lawrence J Mandarino, Chad C Carroll, Christos S Katsanos

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Branched Chain Amino Acids.Annual review of physiology · 2019
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sarah EvermanCenter for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America.
Lawrence J MandarinoCenter for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America; School of Life Sciences, Arizona State University,Tempe, Arizona, United States of America.
Chad C CarrollDepartment of Physiology, Midwestern University, Glendale, Arizona, United States of America.
Christos S KatsanosCenter for Metabolic and Vascular Biology, Arizona State University/Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America; School of Life Sciences, Arizona State University,Tempe, Arizona, United States of America.
Mayo Clinic in Arizona · USArizona State University · USMidwestern University · US

Funding

TECHNOLOGY NMR SPECTROSCOPYU24DK100469 · NIDDK · MAYO CLINIC ROCHESTER · PI NAIR, K SREEKUMARAN · 2013 to 2017
$9.0M
Regulation of Muscle ATP Synthase Beta Subunit Metabolism in ObesityR01DK094062 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI KATSANOS, CHRISTOS S · 2012 to 2015
$1.4M
NIDDK NIH HHS R01 DK094062NIDDK NIH HHS R01DK094062NIDDK NIH HHS U24 DK100469
6 · The paper itself

Abstract

backgroundPlasma branched-chain amino acids (BCAA) are inversely related to insulin sensitivity of glucose metabolism in humans. However, currently, it is not known whether there is a cause-and-effect relationship between increased plasma BCAA concentrations and decreased insulin sensitivity.

objectiveTo determine the effects of acute exposure to increased plasma BCAA concentrations on insulin-mediated plasma glucose turnover in humans.

methodsTen healthy subjects were randomly assigned to an experiment where insulin was infused at 40 mU/m2/min (40U) during the second half of a 6-hour intravenous infusion of a BCAA mixture (i.e., BCAA; N = 5) to stimulate plasma glucose turnover or under the same conditions without BCAA infusion (Control; N = 5). In a separate experiment, seven healthy subjects were randomly assigned to receive insulin infusion at 80 mU/m2/min (80U) in association with the above BCAA infusion (N = 4) or under the same conditions without BCAA infusion (N = 3). Plasma glucose turnover was measured prior to and during insulin infusion.

resultsInsulin infusion completely suppressed the endogenous glucose production (EGP) across all groups. The percent suppression of EGP was not different between Control and BCAA in either the 40U or 80U experiments (P > 0.05). Insulin infusion stimulated whole-body glucose disposal rate (GDR) across all groups. However, the increase (%) in GDR was not different [median (1st quartile - 3rd quartile)] between Control and BCAA in either the 40U ([199 (167-278) vs. 186 (94-308)] or 80 U ([491 (414-548) vs. 478 (409-857)] experiments (P > 0.05). Likewise, insulin stimulated the glucose metabolic clearance in all experiments (P < 0.05) with no differences between Control and BCAA in either of the experiments (P > 0.05).

conclusionShort-term exposure of young healthy subjects to increased plasma BCAA concentrations does not alter the insulin sensitivity of glucose metabolism.

Indexed as

AdultAmino Acids, Branched-ChainBlood GlucoseFemaleHumansInsulinMaleAmino Acids, Branched-ChainBlood GlucoseInsulin

Identifiers

PMID25781654
PMCPMC4363593
OpenAlexW2078704271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.